Moving Beyond AI Hype to Measurable Commercial Impact

In this episode of The Syneos Health Podcast: Conversations on Commercialization, Commercial VP and Host, Tyler Cowan, speaks with Tim Jones, SVP, Commercial Excellence and Business Intelligence and Melissa Bojorquez, VP, AI Customer Engagement, about how artificial intelligence (AI), data and technology are reshaping biopharmaceutical commercialization.

The conversation explores practical applications of AI in pharma commercialization, including smarter targeting, more personalized healthcare professional (HCP) engagement, faster decision-making and new approaches to commercial deployment. Tim and Melissa also share examples of how AI-enabled strategies can improve productivity, optimize channel mix and uncover growth opportunities in areas such as rare disease.

Listeners will hear how Syneos Health is moving AI beyond experimentation to support measurable business impact—and why the opportunity is less about replacing people and more about helping commercial teams work smarter, respond faster and focus on higher-value customer needs.

This episode is a preview of the practical AI, HCP engagement and commercialization strategies we’ll present at Fierce Pharma Week 2026, including how AI can support more personalized engagement, smarter next best action and accelerated commercial growth.

Like what you’re hearing? Find the full Conversations on Commercialization podcast stream here. 

Also available anywhere you listen to podcasts.
Apple | Spotify | Amazon Music | YouTube

Be sure to rate and review us!

We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].